Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Ghetie, V' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 45 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Firan, M; Bawdon, R; Radu, C; Ober, RJ; Eaken, D; Antohe, F; Ghetie, V; Ward, ES
      The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans

      INTERNATIONAL IMMUNOLOGY
    2. Ober, RJ; Radu, CG; Ghetie, V; Ward, ES
      Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies

      INTERNATIONAL IMMUNOLOGY
    3. Antohe, F; Radulescu, L; Gafencu, A; Ghetie, V; Simionescu, M
      Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells

      HUMAN IMMUNOLOGY
    4. Messmann, RA; Vitetta, ES; Headlee, D; Senderowicz, AM; Figg, WD; Schindler, J; Michiel, DF; Creekmore, S; Steinberg, SM; Kohler, D; Jaffe, ES; Stetler-Stevenson, M; Chen, HC; Ghetie, V; Sausville, EA
      A phase I study of combination therapy with immunotoxins IgG-HD37-deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma

      CLINICAL CANCER RESEARCH
    5. Schnell, R; Vitetta, E; Schindler, J; Borchmann, P; Barth, S; Ghetie, V; Hell, K; Drillich, S; Diehl, V; Engert, A
      Treatment of refractory Hodgkin's lymphoma patients with an anti-CD25 ricin A-chain immunotoxin

      LEUKEMIA
    6. Ghetie, V; Ward, ES
      Multiple roles for the major histocompatibility complex class I-related receptor FcRn

      ANNUAL REVIEW OF IMMUNOLOGY
    7. Baluna, R; Coleman, E; Jones, C; Ghetie, V; Vitetta, ES
      The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro: Insights into toxin-mediated vascular damage

      EXPERIMENTAL CELL RESEARCH
    8. Ghetie, V; Vitetta, ES
      Chemical construction of immunotoxins

      DRUG TARGETING
    9. Ghetie, MA; Ghetie, V; Vitetta, ES
      Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cell

      CLINICAL CANCER RESEARCH
    10. Baluna, R; Rizo, J; Gordon, BE; Ghetie, V; Vitetta, ES
      Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    11. Kim, JK; Firan, M; Radu, CG; Kim, CH; Ghetie, V; Ward, ES
      Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn

      EUROPEAN JOURNAL OF IMMUNOLOGY
    12. Cianga, P; Medesan, C; Richardson, JA; Ghetie, V; Ward, ES
      Identification and function of neonatal Fc receptor in mammary gland of lactating mice

      EUROPEAN JOURNAL OF IMMUNOLOGY
    13. Pinkerton, SD; Rolfe, R; Auld, DL; Ghetie, V; Lauterbach, BF
      Selection of castor for divergent concentrations of ricin and Ricinus communis agglutinin

      CROP SCIENCE
    14. SCHNELL R; VITETTA E; SCHINDLER J; BARTH S; WINKLER U; BORCHMANN P; HANSMANN ML; DIEHL V; GHETIE V; ENGERT A
      CLINICAL-TRIALS WITH AN ANTI-CD25 RICIN A-CHAIN EXPERIMENTAL AND IMMUNOTOXIN (RFT5-SMPT-DGA) IN HODGKINS-LYMPHOMA

      Leukemia & lymphoma
    15. BORVAK J; RICHARDSON J; MEDESAN C; ANTOHE F; RADU C; SIMIONESCU M; GHETIE V; WARD ES
      FUNCTIONAL EXPRESSION OF THE MHC CLASS I-RELATED RECEPTOR, FCRN, IN ENDOTHELIAL-CELLS OF MICE

      International immunology (Print)
    16. MEDESAN C; CIANGA P; MUMMERT M; STANESCU D; GHETIE V; WARD ES
      COMPARATIVE-STUDIES OF RAT IGG TO FURTHER DELINEATE THE FC-FCRN INTERACTION SITE

      European Journal of Immunology
    17. GHETIE V; POPOV S; BORVAK J; RADU C; MATESOI D; MEDESAN C; OBER RJ; WARD ES
      INCREASING THE SERUM PERSISTENCE OF AN IGG FRAGMENT BY RANDOM MUTAGENESIS

      Nature biotechnology
    18. KAPLAN LD; ROBLES R; KAHN JO; SCHINDLER J; GHETIE V; VITETTA ES
      PHASE-1 TRIAL OF ANTI-CD22 RICIN-A-CHAIN IMMUNOTOXIN (IGG-RFB4-DGA) FOR TREATMENT OF AIDS-LYMPHOMA

      Journal of acquired immune deficiency syndromes and human retrovirology
    19. GHETIE MA; GHETIE V; VITETTA ES
      IMMUNOTOXINS FOR THE TREATMENT OF B-CELL LYMPHOMAS

      Molecular medicine
    20. GHETIE V; WARD ES
      FCRN - THE MHC CLASS I-RELATED RECEPTOR THAT IS MORE THAN AN IGG TRANSPORTER

      Immunology today
    21. MEDESAN C; MATESOI D; RADU C; GHETIE V; WARD ES
      DELINEATION OF THE AMINO-ACID-RESIDUES INVOLVED IN TRANSCYTOSIS AND CATABOLISM OF MOUSE IGG1

      The Journal of immunology
    22. SCHNELL R; VITETTA E; SCHINDLER J; BOHLEN H; HANSMANN ML; BARTH S; GHETIE V; UHR J; DIEHLL V; ENGERT A
      A CLINICAL-PHASE-I II TRIAL WITH AN ANTI-CD25 RICIN A-CHAIN IMMUNOTOXIN (RFT5-SMPT-DGA) IN PATIENTS WITH REFRACTORY HODGKINS LYMPHOMA/

      Blood
    23. ENGERT A; DIEHL V; SCHNELL R; RADSZUHN A; HATWIG MT; DRILLICH S; SCHON G; BOHLEN H; TESCH H; HANSMANN ML; BARTH S; SCHINDLER J; GHETIE V; UHR J; VITETTA E
      A PHASE-I STUDY OF AN ANTI-CD25 RICIN A-CHAIN IMMUNOTOXIN (RFT5-SMPT-DGA) IN PATIENTS WITH REFRACTORY HODGKINS LYMPHOMA

      Blood
    24. SENDEROWICZ AM; VITETTA E; HEADLEE D; GHETIE V; UHR JW; FIGG WD; LUSH RM; STETLERSTEVENSON M; KERSHAW G; KINGMA DW; JAFFE ES; SAUSVILLE EA
      COMPLETE SUSTAINED RESPONSE OF A REFRACTORY, POSTTRANSPLANTATION, LARGE B-CELL LYMPHOMA TO AN ANTI-CD22 IMMUNOTOXIN

      Annals of internal medicine
    25. BALUNA R; GHETIE V; OPPENHEIMERMARKS N; VITETTA ES
      FIBRONECTIN INHIBITS THE CYTOTOXIC EFFECT OF RICIN-A CHAIN ON ENDOTHELIAL-CELLS

      International journal of immunopharmacology
    26. POPOV S; HUBBARD JG; KIM JK; OBER B; GHETIE V; WARD ES
      THE STOICHIOMETRY AND AFFINITY OF THE INTERACTION OF MURINE FC FRAGMENTS WITH THE MHC CLASS I-RELATED RECEPTOR, FCRN

      Molecular immunology
    27. GHETIE V; HUBBARD JG; KIM JK; TSEN MF; LEE YF; WARD ES
      ABNORMALLY SHORT SERUM HALF-LIVES OF IGG IN BETA-2-MICROGLOBULIN-DEFICIENT MICE

      European Journal of Immunology
    28. MEDESAN C; RADU C; KIM JK; GHETIE V; WARD ES
      LOCALIZATION OF THE SITE OF THE IGG MOLECULE THAT REGULATES MATERNOFETAL TRANSMISSION IN MICE

      European Journal of Immunology
    29. STONE MJ; SAUSVILLE EA; FAY JW; HEADLEE D; COLLINS RH; FIGG WD; STETLERSTEVENSON M; JAIN V; JAFFE ES; SOLOMON D; LUSH RM; SENDEROWICZ A; GHETIE V; SCHINDLER J; UHR JW; VITETTA ES
      A PHASE-I STUDY OF BOLUS VERSUS CONTINUOUS-INFUSION OF THE ANTI-CD19 IMMUNOTOXIN, IGG-HD37-DGA, IN PATIENTS WITH B-CELL LYMPHOMA

      Blood
    30. CONRY RM; KHAZAELI MB; SALEH MN; GHETIE V; VITETTA ES; LIU TP; LOBUGLIO AF
      PHASE-I TRIAL OF AN ANTI-CD19 DEGLYCOSYLATED RICIN-A CHAIN IMMUNOTOXIN IN NON-HODGKINS-LYMPHOMA - EFFECT OF AN INTENSIVE SCHEDULE OF ADMINISTRATION

      Journal of immunotherapy with emphasis on tumor immunology
    31. SCHNELL R; HATWIG MT; RADSZUHN A; CEBE F; DRILLICH S; SCHON G; BOHLEN H; HANSMANN ML; SCHINDLER J; GHETIE V; UHR J; DIEHL V; VITETTA ES; ENGERT A
      A CLINICAL-PHASE-I STUDY OF AN ANTI-CD25-DEGLYCOSYLATED RICIN A-CHAINIMMUNOTOXIN (RFT5-SMPT-DGA) IN PATIENTS WITH REFRACTORY HODGKINS-DISEASE

      European journal of cancer
    32. GHETIE V; ENGERT A; SCHNELL R; VITETTA ES
      THE IN-VIVO ANTITUMOR-ACTIVITY OF IMMUNOTOXINS CONTAINING 2 VERSUS ONE DEGLYCOSYLATED RICIN-A CHAINS

      Cancer letters
    33. KIM JK; TSEN MF; GHETIE V; WARD ES
      EVIDENCE THAT THE HINGE REGION PLAYS A ROLE IN MAINTAINING SERUM LEVELS OF THE MURINE IGG1 MOLECULE

      Molecular immunology
    34. SAUSVILLE EA; HEADLEE D; STETLERSTEVENSON M; JAFFE ES; SOLOMON D; FIGG WD; HERDT J; KOPP WC; RAGER H; STEINBERG SM; GHETIE V; SCHINDLER J; UHR J; WITTES RE; VITETTA ES
      CONTINUOUS-INFUSION OF THE ANTI-CD22 IMMUNOTOXIN IGG-RFB4-SMPT-DGA INPATIENTS WITH B-CELL LYMPHOMA - A PHASE-I STUDY

      Blood
    35. KIM JK; TSEN MF; GHETIE V; WARD ES
      MAPPING THE SITE THAT CONTROLS THE CATABOLISM OF THE MURINE IGG1 MOLECULE BY SITE-DIRECTED MUTAGENESIS

      The FASEB journal
    36. GHETIE V; SWINDELL E; UHR JW; VITETTA ES
      THE GENERATION OF IMMUNOTOXINS CONTAINING ONE OR 2 TOXIN MOLECULES BOUND TO ANTIBODY

      The FASEB journal
    37. NOON E; GHETIE V; VITETTA E
      DECREASING THE IMMUNOGENICITY OF RICIN A-CHAIN

      The FASEB journal
    38. KIM JK; TSEN MF; GHETIE V; WARD ES
      CATABOLISM OF THE MURINE IGG1 MOLECULE - EVIDENCE THAT BOTH CH2-CH3 DOMAIN INTERFACES ARE REQUIRED FOR PERSISTENCE OF IGG1 IN THE CIRCULATION OF MICE

      Scandinavian journal of immunology
    39. GHETIE V; VITETTA E
      IMMUNOTOXINS IN THE THERAPY OF CANCER - FROM BENCH TO CLINIC

      Pharmacology & therapeutics
    40. KIM JK; TSEN MF; GHETIE V; WARD ES
      IDENTIFYING AMINO-ACID-RESIDUES THAT INFLUENCE PLASMA-CLEARANCE OF MURINE IGG1 FRAGMENTS BY SITE-DIRECTED MUTAGENESIS

      European Journal of Immunology
    41. KIM JK; TSEN MF; GHETIE V; WARD ES
      LOCALIZATION OF THE SITE OF THE MURINE IGG1 MOLECULE THAT IS INVOLVEDIN BINDING TO THE MURINE INTESTINAL FC RECEPTOR

      European Journal of Immunology
    42. TONG AW; HUANG YW; GHETIE V; NEMUNAITIS J; PINEIRO L; VITETTA E; STONE MJ
      ENHANCEMENT OF ANTI-CD54 IMMUNOTOXIN CYTOTOXICITY TO HUMAN MULTIPLE-MYELOMA CELLS BY CYCLOSPORINE DRUGS

      Blood
    43. ENGERT A; SCHNELL R; RADZHUN A; HARTWIG MT; DRILLICH S; SCHON G; GEBHARD J; POYRAZ S; BOHLEN H; TESCH H; HANSMANN ML; SCHINDLER J; GHETIE V; UHR J; DIEHL V; VITETTA ES
      A PHASE-I STUDY OF AN ANTI-CD25 RICIN A-CHAIN IMMUNOTOXIN IN PATIENTSWITH REFRACTORY HODGKINS LYMPHOMA

      Blood
    44. GHETIE V; SWINDELL E; UHR JW; VITETTA ES
      PURIFICATION AND PROPERTIES OF IMMUNOTOXINS CONTAINING ONE VS 2 DEGLYCOSYLATED RICIN-A CHAINS

      Journal of immunological methods
    45. AMLOT PL; STONE MJ; CUNNINGHAM D; FAY J; NEWMAN J; COLLINS R; MAY R; MCCARTHY M; RICHARDSON J; GHETIE V; RAMILO O; THORPE PE; UHR JW; VITETTA ES
      A PHASE-I STUDY OF AN ANTI-CD22-DEGLYCOSYLATED RICIN-A CHAIN IMMUNOTOXIN IN THE TREATMENT OF B-CELL LYMPHOMAS RESISTANT TO CONVENTIONAL THERAPY

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 14:08:15